Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.640
-0.050 (-2.96%)
At close: Nov 3, 2026, 4:00 PM EST
1.610
-0.030 (-1.83%)
Pre-market: Nov 4, 2026, 4:50 AM EST
PYXS's stock price has decreased by -53.93% in the past year and price targets may not have had time to catch up.
Pyxis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Reiterates $19 | Buy | Reiterates | $19 | +1,058.54% | Oct 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $6 | Buy | Maintains | $6 | +265.85% | Oct 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +387.80% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +387.80% | Sep 26, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $7 | Buy | Maintains | $7 | +326.83% | Aug 18, 2026 |
| Wedbush | Wedbush | Buy Reiterates $6 | Buy | Reiterates | $6 | +265.85% | Aug 14, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $7 | Buy | Maintains | $7 | +326.83% | Jun 30, 2026 |